Table 2

Baseline patient characteristics of included patients (N=107)

High flow (n=55)Low flow (n=52)
Male sex33 (60.0)31 (59.6)
Age (months), median (IQR)4.95 (2.0–10.0)3.97 (1.9–10.7)
 0–15 (9.1)7 (13.5)
 1–318 (32.7)15 (28.8)
 3–1222 (40.0)19 (36.5)
 >1210 (18.2)11 (21.2)
Birth weight (kg), median (IQR)*3.4 (3.1–3.8)3.4 (2.9–3.8)
Gestational age (weeks+days), median (IQR)†39+4 (38+2–40+3)38+6 (37+4–40+1)
 < 37+0 weeks8 (15.7)8 (17.4)
Clinical signs at the start of the intervention
 VWS, median (IQR)‡6 (6 – 8)7 (6 – 8)
 Respiratory rate (breaths/min), mean (SD)§53 (12)53 (14)
 Heart rate (beats/min), mean (SD)§165 (17)165 (19)
 Retractions¶48 (98)50 (100)
 Severe retractions12 (25)9 (18)
 FLACC, median (IQR)**3.5 (1.0–5.0)4.0 (2.0–5.0)
Winter season
 2016–201711 (20.0)12 (23.1)
 2017–201819 (34.5)21 (40.4)
 2018–201912 (21.8)8 (15.4)
 2019–202013 (23.6)11 (21.2)
Study site††
 15 (9.1)4 (7.7)
 27 (12.7)7 (13.5)
 32 (3.6)2 (3.8)
 431 (56.4)31 (59.6)
 510 (18.2)8 (15.4)
  • N (%) unless stated otherwise.

  • VWS adapted from Fuijkschot et al.18

  • *Data missing in 15 patients.

  • †Data missing in 10 patients.

  • ‡Data missing in 2 patients.

  • §Data missing in 5 patients.

  • ¶Data missing in 8 patients.

  • **Data missing in 24 patients.

  • ††1=Amphia, Breda; 2=Deventer Ziekenhuis; 3=Ikazia, Rotterdam; 4=Isala, Zwolle; 5=Martini, Groningen.

  • FLACC, face, legs, activity, cry, consolability; VWS, Vital Warning Score.